Cite
HARVARD Citation
Schuster, S. et al. (2022). Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison. Leukemia & lymphoma. 63 (4), pp. 845-854. [Online].